Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyAbout this site
GCP Center · Cancer Hospital of Chinese Academy of Medical Sciences · Beijing

Dr. Wang Shuhang王书航

Associate Chief Physician

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Wang Shuhang

Professional overview

An Associate Chief Physician at Cancer Hospital of Chinese Academy of Medical Sciences, working in the GCP Center, focusing on clinical trials of novel anti-tumor drugs and technologies.

SpecialtyGCP Center
Clinical titleAssociate Chief Physician
Academic roles—
DepartmentGCP Center
HospitalCancer Hospital of Chinese Academy of Medical Sciences
CityBeijing
Hospital roleClinical Secretary, Drug Clinical Trial Research Center (GCP)

Areas of focus

Clinical trials of novel anti-tumor drugs and technologiesFocuses on clinical trials of novel anti-tumor drugs and technologies.
Precision treatment of rare tumorsFocuses on individualized targeted and immunotherapy for rare tumors.
Comprehensive treatment of thoracic malignanciesFocuses on comprehensive treatment of non-small cell lung cancer, small cell lung cancer, malignant pleural mesothelioma, and carcinoid tumors.

Background

  • 2010Received National Natural Science Foundation of China (NSFC) Youth Fund.
  • 2013Received American Society of Clinical Oncology (ASCO) IDEA Grant.
  • 2015Postdoctoral fellow in Thoracic Medical Oncology at Roswell Park Comprehensive Cancer Center, focusing on thoracic malignancies and Phase I clinical trials.
  • 2016Postdoctoral fellow in New Drug Development and Immunology at Mayo Clinic, focusing on clinical research of novel oncology drugs and immune translational research.
  • 2017Received ASCO LIFE Grant.

Experience & recognition

  • First-author publications in Cancer Cell, Journal of Thoracic Oncology, Journal of Genetics and Genomics, and Frontiers in Oncology.
  • Published in Journal of Clinical Oncology and received ASCO Merit Award during graduate studies.
  • PhD from Peking University.
  • Published dissertation in Clinical Cancer Research.
  • Served as reviewer for Journal of Thoracic Oncology.
  • Member of the National Medical Products Administration (NMPA) clinical trial inspection team.

Professional roles

  • Member, Clinical Research Committee, Beijing Cancer Society
  • Member, Clinical Expert Committee, Beijing Health Promotion Association
  • Youth Committee Member, Tumor Biomarkers Professional Committee, China Anti-Cancer Association (CACA)
  • Editorial Board Member, Journal of Thoracic Oncology

Frequently asked questions

What does Dr. Wang Shuhang specialize in?

Focuses on clinical trials of novel anti-tumor drugs and technologies; precision treatment of rare tumors including targeted therapy, chemotherapy, and immunotherapy; and comprehensive treatment of thoracic malignancies such as non-small cell lung cancer, small cell lung cancer, malignant pleural mesothelioma, and carcinoid tumors.

Which hospital and department is Dr. Wang Shuhang in?

Works in the GCP Center at Cancer Hospital of Chinese Academy of Medical Sciences.

Sources

Dr. Wang Shuhang has not reviewed this page.